• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  09/28/2010
 
Trade Name:  Kapvay Extended Release Tablets
 
Generic or Proper Name (*):  clonidine
 
Indications Studied:  Treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications
 
Therapeutic Category:  Non-stimulant ADHD treatment
 
Ages Studied:  6-17 years
 
Study #:  3
 
Study Type:  Safety
 
Study Design:  Open Label
 
No Patients:  303
 
No Centers:  27
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
-
-